Tuesday, March 04, 2025 | 03:39 PM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Aarti Drugs Q3 net dips 10 pc at Rs 20.89 cr

Image

Press Trust of India New Delhi

Drug firm Aarti Drugs Monday reported a 10.45 per cent dip in its consolidated net profit to Rs 20.89 crore for the quarter ended December 31, 2018.

The company had posted a net profit of Rs 23.33 crore for the corresponding period of the previous fiscal, Aarti Drugs said in a filing to BSE.

Consolidated revenue from operations of the company however stood at Rs 380.11 crore for the quarter under consideration as against Rs 335.41 crore for October-December 2017.

Shares of Aarti Drugs closed at Rs 592.70 on BSE, up 1.50 per cent from the previous close.

Disclaimer: No Business Standard Journalist was involved in creation of this content

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Feb 11 2019 | 4:05 PM IST

Explore News